Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Trial of an Investigational Drug for the Prevention of Diarrhea Associated With Irinotecan/5FU/Leucovorin Chemotherapy in Previously Untreated Metastatic Colorectal Cancer

This study has been terminated.
Sponsor:
Collaborator:
Pfizer
Information provided by:
Celgene Corporation
ClinicalTrials.gov Identifier:
NCT00040391
First received: June 26, 2002
Last updated: March 13, 2007
Last verified: March 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given